BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 21316001)

  • 1. Nosocomial fungal infections: epidemiology, infection control, and prevention.
    Alangaden GJ
    Infect Dis Clin North Am; 2011 Mar; 25(1):201-25. PubMed ID: 21316001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.
    Suleyman G; Alangaden GJ
    Infect Dis Clin North Am; 2021 Dec; 35(4):1027-1053. PubMed ID: 34752219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial fungal infections. Old problems and new challenges.
    Anaissie E; Bodey GP
    Infect Dis Clin North Am; 1989 Dec; 3(4):867-82. PubMed ID: 2687366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology and prevention of nosocomial invasive infections by filamentous fungi and yeasts].
    Pemán J; Salavert M
    Enferm Infecc Microbiol Clin; 2013 May; 31(5):328-41. PubMed ID: 23561595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial fungal infections: epidemiology, diagnosis, and treatment.
    Perlroth J; Choi B; Spellberg B
    Med Mycol; 2007 Jun; 45(4):321-46. PubMed ID: 17510856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of invasive fungal infection.
    Castón-Osorio JJ; Rivero A; Torre-Cisneros J
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S103-9. PubMed ID: 19013332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi].
    Ruiz-Camps I; Aguado JM; Almirante B; Bouza E; Ferrer Barbera C; Len O; López-Cerero L; Rodríguez-Tudela JL; Ruiz M; Solé A; Vallejo C; Vázquez L; Zaragoza R; Cuenca-Estrella M;
    Enferm Infecc Microbiol Clin; 2010 Mar; 28(3):172.e1-172.e21. PubMed ID: 20202721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and control of nosocomial and health-care facilities associated infections caused by species of Candida and other yeasts].
    Pemán J; Zaragoza R; Salavert M
    Rev Esp Quimioter; 2013 Dec; 26(4):298-311. PubMed ID: 24399344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies.
    Murali S; Langston A
    Transpl Infect Dis; 2009 Dec; 11(6):480-90. PubMed ID: 19725908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.
    Suleyman G; Alangaden GJ
    Infect Dis Clin North Am; 2016 Dec; 30(4):1023-1052. PubMed ID: 27816138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The epidemiology of invasive fungal infection].
    Ma J
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1443-4. PubMed ID: 16061016
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis of invasive mycoses in solid organ transplantation.
    Alexander BD
    Curr Opin Infect Dis; 2002 Dec; 15(6):583-9. PubMed ID: 12821834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive fungal infections in the ICU.
    Shoham S; Marwaha S
    J Intensive Care Med; 2010; 25(2):78-92. PubMed ID: 19955115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit.
    Smith JA; Kauffman CA
    Crit Care Med; 2010 Aug; 38(8 Suppl):S380-7. PubMed ID: 20647796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing epidemiology of invasive fungal infections: new threats.
    Maschmeyer G
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungus fighters. AIA, CDC and JCAHO battle nosocomial infection rate.
    Burmahl B
    Health Facil Manage; 2000 May; 13(5):14-6, 18, 20. PubMed ID: 11183984
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing patterns and trends in systemic fungal infections.
    Richardson MD
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i5-i11. PubMed ID: 16120635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.